Clinical Trials Rare diseases: how can decentralisation speed up trials and reduce patient burden? 26 Feb 2021
Novartis starts Phase III trials of ligelizumab for urticaria Novartis has commenced a pair of Phase III trials to evaluate the efficacy and safety... 4th December 2018